课题基金 / 基金详情

Development and Preclinical Testing of the TORVAD Ventricular Assist System in Preparation for First in Human Implantation

Development and Preclinical Testing of the TORVAD Ventricular Assist System in Preparation for First in Human Implantation
TORVAD 心室辅助系统的开发和临床前测试,为首次人体植入做准备
批准号:
9272930
负责人:
Jeffrey Robert Gohean
金额:
$99.98万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-23 至 2020-04-30

项目摘要

项目成果

Jeffrey Robert Gohean的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): The TORVAD(tm) is a unique ventricular assist system that delivers low-shear, synchronous, pulsatile flow. Blood shear due to pumping is minimized by the relatively low speed of pistons supported by hydrodynamic bearings designed to maintain a fixed gap between the piston and torus walls. The TORVAD synchronizes with the heart to preserve aortic valve flow and maintains autoregulation of cardiac output by the Frank-Starling mechanism. The design of the TORVAD also allows for inherent determination of differential pump pressure, without additional sensors, which can be used to manage patient medications and pump flow rates. These advantages have been confirmed in preliminary studies. In vitro tests have demonstrated that the low-shear design preserves high-molecular-weight von Willebrand factor and results in significantly reduced hemolysis as compared to clinically available continuous flow devices. The TORVAD's hematological results are unmatched by any other ventricular assist device. In addition, synchronous hemodynamics have been demonstrated using acute and chronic animal models. These preliminary findings demonstrate that the TORVAD has the potential to reduce bleeding, thrombus formation, and strokes that are associated with the use of other ventricular assist devices. The goal of this project is to bridge the TORVAD from R&D to first-in-human clinical trials by conducting the verification and validation steps necessary to determine the safety of the TORVAD system and to apply for an Investigational Device Exemption (IDE) for an Early Feasibility Study. This will be accomplished as follows: 1) Use previous experience with prototypes to finalize the design, implement design controls, and perform risk analysis on the system; 2) Fabricate and assemble 35 systems for testing; 3) Perform subsystem verification testing; 4) Complete in vitro design evaluation and system performance testing to confirm device performance and reliability; 5) Conduct in vivo acute and chronic animal experiments to demonstrate device safety; and 6) Apply for an IDE for an early feasibility study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pediatric Implantable Low-Shear Pulsatile Blood Pump with Physiologic Sensing and Control
Pediatric Implantable Low-Shear Pulsatile Blood Pump with Physiologic Sensing and Control
Miniaturization of the low-shear pulsatile TORVAD for pediatric heart failure
Development and Preclinical Testing of the TORVAD Ventricular Assist System in Preparation for First in Human Implantation
海外基金